View in EDS HTML Full Text PDF Full Text

Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.

Saved in:

Bibliographic Details
Title:	Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.
Authors:	Mirioglu, Safak^1,2 (AUTHOR) smirioglu@gmail.com, Hocaoglu, Rabia Hacer¹ (AUTHOR), Velioglu, Arzu³ (AUTHOR), Ozluk, Yasemin⁴ (AUTHOR), Dirim, Ahmet Burak¹ (AUTHOR), Oruc, Aysegul⁵ (AUTHOR), Oto, Ozgur Akin¹ (AUTHOR), Yazici, Halil¹ (AUTHOR), Caliskan, Yasar^1,6 (AUTHOR)
Source:	Clinical Kidney Journal. Jul2024, Vol. 17 Issue 7, p1-3. 3p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20488505
DOI:	10.1093/ckj/sfae190